|
|
||||||||
The Journal of Immunology, Vol 147, Issue 9 2875-2882, Copyright © 1991 by American Association of Immunologists
ARTICLES |
Y St. Pierre and TH Watts
Department of Immunology, University of Toronto, Ontario, Canada.
In addition to their role as peptide binding proteins, MHC class II proteins can also function as signal transducing molecules. Recent work using B cells expressing genetically engineered truncated MHC class II molecules has suggested that signaling through the cytoplasmic domains of these proteins plays an important role in the generation of signals required for the activation of some T cell hybrids. Treatment of truncated Ia-expressing B cells with cAMP-elevating agents corrects the deficiency in Ag presentation by these cells. We report that the MHC class II-mediated signal appears to act by a mechanism that increases the efficiency of Ag presentation by B cells thereby lowering the amount of specific Ag required for T cell activation. We further show that the induction of the cAMP-induced signal in B cells is inhibited by cycloheximide and cytochalasin A, implicating protein synthesis as well as cytoskeletal rearrangements in Ag presentation to accessory signal- dependent hybrids. In contrast, these agents do not block Ag presentation to a T cell hybrid previously shown not to require the cAMP-induced signal for activation. The signal-dependent T hybrid is additionally dependent on LFA-1-ICAM-1 interaction for activation, whereas the signal-independent hybrid is not. These observations suggest the existence of two types of T cell hybrid with respect to their requirements for activation: those that require only the recognition of MHC class II-peptide complexes without accessory signals, as shown by their ability to respond to purified Ia on planar membranes, and those that, in addition to recognition of MHC II/Ag, require LFA-1-ICAM-1 interaction and the delivery of additional signal(s) induced in the B cell via signal transduction through MHC class II molecules.
This article has been cited by other articles:
![]() |
M. Shimoda, T. Li, J. P. S. Pihkala, and P. A. Koni Role of MHC Class II on Memory B Cells in Post-Germinal Center B Cell Homeostasis and Memory Response J. Immunol., February 15, 2006; 176(4): 2122 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, S. Becart, D. Charron, and N. Mooney B Cell Lipid Rafts Regulate Both Peptide-Dependent and Peptide-Independent APC-T Cell Interaction J. Immunol., August 1, 2004; 173(3): 1876 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Jordan, D. M. Mills, J. Kappler, P. Marrack, and J. C. Cambier Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population Science, June 18, 2004; 304(5678): 1808 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, V. Blancheteau, A. Delaguillaumie, F. Michel, S. Becart, G. Lombardi, O. Acuto, D. Charron, and N. Mooney Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells J. Leukoc. Biol., June 1, 2004; 75(6): 1036 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. El Fakhry, M. Bouillon, C. Leveille, A. Brunet, H. Khalil, J. Thibodeau, and W. Mourad Delineation of the HLA-DR Region and the Residues Involved in the Association with the Cytoskeleton J. Biol. Chem., April 30, 2004; 279(18): 18472 - 18480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Dolan, T. P. Phelan, D. Ilkovitch, L. Qi, W. F. Wade, T. M. Laufer, and S. Ostrand-Rosenberg Invariant Chain and the MHC Class II Cytoplasmic Domains Regulate Localization of MHC Class II Molecules to Lipid Rafts in Tumor Cell-Based Vaccines J. Immunol., January 15, 2004; 172(2): 907 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Mills, J. C. Stolpa, and J. C. Cambier Cognate B Cell Signaling via MHC Class II: Differential Regulation of B Cell Antigen Receptor and MHC Class II/Ig-{alpha}{beta} Signaling by CD22 J. Immunol., January 1, 2004; 172(1): 195 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Becart, N. Setterblad, S. Ostrand-Rosenberg, S. J. Ono, D. Charron, and N. Mooney Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-dependent signaling J. Cell Sci., June 15, 2003; 116(12): 2565 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bobbitt and L. B. Justement Regulation of MHC Class II Signal Transduction by the B Cell Coreceptors CD19 and CD22 J. Immunol., November 15, 2000; 165(10): 5588 - 5596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Etienne, S. Bourdoulous, A. D. Strosberg, and P.-O. Couraud MHC Class II Engagement in Brain Endothelial Cells Induces Protein Kinase A-Dependent IL-6 Secretion and Phosphorylation of cAMP Response Element-Binding Protein J. Immunol., October 1, 1999; 163(7): 3636 - 3641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Greer, J. Lin, C. H. Clarke, and L. B. Justement Major Histocompatibility Class II-mediated Signal Transduction Is Regulated by the Protein-tyrosine Phosphatase CD45 J. Biol. Chem., May 8, 1998; 273(19): 11970 - 11979. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |